WeVote
Log In

Bill

Bill

SB 1102

Relating to the administration of certain drugs by a midwife.

89th Legislature (2025) Introduced by Angela Paxton

Texas bill expands midwife authority to independently administer specified medications during childbirth and postpartum care without mandatory physician oversight.

Referred to Health & Human Services
#continuingeducation(s0234) #licensing&regulation #texascommissionof(v0383) #medicine&prescriptiondrugs(s7338) #midwives&midwifery(s0762) #occupationalregulation--healthoccupations(i0540) #pregnancy&childbirth(s0294) #women(i0925)
0
WeVote Research Nonpartisan
Bill Summary · SB 1102

Legislative bill overview

SB 1102 expands the scope of practice for midwives in Texas by permitting them to administer certain medications during childbirth and postpartum care. The bill modifies existing regulations governing what drugs midwives are authorized to use in their clinical practice without requiring physician supervision for specific, defined medications.

Why is this important

Access to midwifery services affects maternal healthcare delivery, particularly in rural or underserved Texas communities where midwives may be the primary birth attendants. Expanding midwife authority could reduce reliance on physician oversight for routine obstetric medications, potentially improving care coordination and reducing delays in emergency situations, though it also raises questions about clinical oversight and standardization.

Potential points of contention

  • Scope of practice boundaries: Defining which drugs midwives can safely administer without clearer liability and accountability structures may concern physician groups and medical boards about patient safety standards
  • Clinical training and certification: Questions about whether current midwife credentialing and training adequately prepare practitioners for independent medication administration in variable clinical settings
  • Rural vs. urban implications: The bill may create different care standards between areas with physician availability versus remote regions, raising equity concerns about consistency of clinical protocols

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.